Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022.
Gac Sanit
; 37: 102312, 2023.
Article
em En
| MEDLINE
| ID: mdl-37331154
ABSTRACT
OBJECTIVE:
To estimate the seroprevalence of SARS-CoV-2 antibodies in the Valencian Community (Spain) in October 2022, when BA.5 was the predominant variant.METHOD:
Cross-sectional, region-wide, population-based serosurvey study in 88 randomly selected primary care centers of the Valencian Community.RESULTS:
Seroprevalence of anti-nucleocapsid (indicative of past infection) and total receptor binding domain (indicative of past infection or vaccination) antibodies was 71.0% (confidence interval [CI] 67.8-74.2) and 98.4% (CI 97.5-99.3), respectively. 66.7% (CI 63.4-70.0) of the population shows hybrid immunity, but only 43.2% in those 80 and over.CONCLUSIONS:
The high proportion of hybrid immunity detected is relevant for public health strategies. A second vaccination booster was advisable in the elderly population.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
SARS-CoV-2
/
COVID-19
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Aged
/
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Gac Sanit
Assunto da revista:
SAUDE PUBLICA
Ano de publicação:
2023
Tipo de documento:
Article